A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation

By Out HJ  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 622-627

Oxford University Press

Access to resources Recommend Favorite

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.

By Bergh C   Howles C M   Borg K   Hamberger L   Josefsson B   Nilsson L   Wikland M  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2133-2139

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F ® ) with highly purified urinary FSH (Metrodin ® HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection

By Frydman R.   Howles C.M.   Truong F.  

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 520-525

Oxford University Press

Access to resources Recommend Favorite

The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

By Devroey P  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 565-566

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon ® ) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation

By Out Henk J.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 29-35

Oxford University Press

Access to resources Recommend Favorite